5339-15-1

Basic information

• Product Name: 1-[2-(4-nitrophenyl)ethyl]piperidine
• CAS NO: 5339-15-1
• Molecular Formula: C₁₃H₁₈N₂O₂
• Molecular Weight: 234.2942
• Mol File: 5339-15-1.mol

Chemical Properties

• Boiling Point: 358.7°C at 760 mmHg
• Flash Point: 170.7°C
• Density: 1.128g/cm³
• Vapor Pressure: 2.5E-05mmHg at 25°C
• Refractive Index: 1.558
• CAS DataBase Reference: 1-[2-(4-nitrophenyl)ethyl]piperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[2-(4-nitrophenyl)ethyl]piperidine(5339-15-1)
• EPA Substance Registry System: 1-[2-(4-nitrophenyl)ethyl]piperidine(5339-15-1)

Safety Data

• Hazardous Substances Data: 5339-15-1(Hazardous Substances Data)

Usage

Chemical structure

Piperidine derivative with a 4-nitrophenylethyl group attached to the nitrogen atom

Applications

Research and development of pharmaceuticals due to potential biological activity

Hazardous nature

Considered a hazardous chemical and may pose health risks if not handled properly

Handling precautions

Should be handled with care and only used in controlled laboratory settings by trained professionals

Regulations

Subject to strict regulations due to its potential therapeutic properties and hazardous nature

Upstream product

• 110-89-4 piperidine 
• 100-13-0 4-nitrostyrene 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 51738-10-4 2,2-dibromo-1-(4-nitrophenyl)ethene 
• 555-16-8 4-nitrobenzaldehdye 
• 103-63-9 1-phenyl-2-bromoethane 
• 105072-35-3 2-(4-nitrophenyl)-1-(piperidin-1-yl)ethan-1-one 

Downstream Products

• 168897-21-0 4-(2-piperidin-1-yl-ethyl)-phenylamine 
• 229003-44-5 7-phenyl-N-[4-(2-piperidinoethyl)phenyl]-3,4-dihydro-naphthalene-2-carboxamide 
• 229004-34-6 N-(4-(2-piperidinoethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide 
• 1567327-20-1 5,6-dimethoxy-2-(4-(2-(piperidin-1-yl)ethyl)phenyl)benzo[d][1,2]selenazol-3(2H)-one 

Relevant articles and documents

Nucleophilic additions to polarized vinylarenes

The addition of nucleophiles to the terminal double bond carbon of a styrene incorporating an electron-withdrawing group at the ortho or para position has been studied. The conditions for this transformation have been optimized and structural modifications to the substrate have been explored. The structural changes included variation of the activating group on the aromatic ring and positioning substituents on the side chain double bond. The study revealed that nitro substitution gave the best results for addition of carbon and nitrogen nucleophiles. Cyano-substituted systems added carbon nucleophiles, but underwent polymerization or degradation with nitrogen nucleophiles. Ethoxycarbonyl-bearing substrates reacted primarily at the ester carbonyl. The reaction generally proceeded well with methyl on the α carbon of the double bond, but was slowed by methyl at the β position. The yields varied from 50% to 97% for 22 examples.

Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease

A series of ebselen derivatives were designed, synthesised and evaluated as inhibitors of cholinesterases (ChEs) and glutathione peroxidase (GPx) mimics. Most of the compounds were found to be potent against AChEs and BuChE, compounds 5e and 5i, proved to be the most potent against AChE with IC50 values of 0.76 and 0.46 μM, respectively. Among these hybrids, most of the compounds were found to be good GPx mimics compare with ebselen. The selected compounds 5e and 5i were also used to determine the catalytic parameters and in vitro hydrogen peroxide scavenging activity. The results indicate that compounds 5e and 5i may be excellent multifunctional agents for the treatment of AD.

Synthesis and biological evaluation of new 4β-anilino-4′-O- demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents

A series of new 4β-anilino-4′-O-demethyl-4-desoxypodophyllotoxin derivatives were prepared and evaluated for their cytotoxicities against four human cancer cell lines including KB, KB/VCR, A549 and 95D. Most compounds showed better growth-inhibition activities against tested cell lines than that of etoposide (VP-16). Preliminary structure-activity relationships (SARs) were concluded and it indicated that the side chains substituted at 4β position of podophyllotoxin significantly influenced the cytotoxic activity, especially for the drug resistance profile. In vivo studies of compound 26c on highly metastatic human lung cancer xenograft in nude mice showed that it can significantly inhibit tumor growth with administrating by oral route.

Substituted indolines which inhibit receptor tyrosine kinases

Indolinones of the formula having an inhibitory effect on receptor tyrosine kinases and cyclin/CDK complexes, as well as on the proliferation of endothelial cells and various tumor cells. Exemplary are: (a) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone, (b) 3-Z-[(1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinone, and (c) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-metboxycarbonyl-2-indolinone.

3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors

The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

Substituted indolinones with kinase inhibitory activity

Substituted indolinones of general formula having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. Exemplary compounds are: 3-Z-[1-(4-(N-Benzyl-N-methyl-aminomethyl)-phenylamino)-1-methyl-methylene]-5-a

Indolinones having kinase inhibitory activity

The present invention relates to substituted indolinones of general formula [Figure] wherein R1 to R5, and X are defined as in claim 1, the isomers thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, particularly an inhibitory effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells, pharmaceutical compositions containing these (compounds, their use and processes for preparing them.

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

The search for new small-molecule CCR5 antagonists by high-throughput screening (HTS) of the Takeda chemical library using [125I]RANTES and CHO/CCR5 cells led to the discovery of lead compounds (A, B) with a quaternary ammonium or phosphonium m

Study into the cyclization of an epoxy-alcohol to the energetically disfavored product by peptides from non-biased combinatorial libraries

Catalysis of a reaction to products via an energetically disfavored pathway to be performed by small molecules is not documented to date. To question that, we chose to study the possible cyclization of an epoxy-alcohol to the product interdicted by Baldwi

Anilide derivative, production and use thereof

This invention is to provide a compound of the formula: wherein R1 is an optionally substituted 5- to 6-membered ring: C is a divalent group of the formula: wherein the ring A is an optionally substituted 5- to 6-membered aromatic ring, X is an optionally substituted C, N or O atom, and the ring B is an optionally substituted 5- to 7-membered ring; Z is a chemical bond or a divalent group; R2 is (1) an optionally substituted amino group in which a nitrogen atom may form a quaternary ammonium, etc., or a salt thereof, which is useful for antagonizing MCP-1 receptor.